Pharmabiz

OGT workshop at ESHG highlights impact of exon-level CNV analysis on accurate detection of genetic disorders

Oxford Gene Technology (OGT), The Molecular Genetics Company, held an exclusive workshop exploring the power of exon-focused microarrays in enhancing genetic syndrome research at the recent European ...
technologynetworks

OGT Releases New CytoSure™ Microarray

Oxford Gene Technology (OGT) has released a new microarray to improve the accuracy and efficiency of cancer research. The CytoSure™ Cancer +SNP array (4x180k) combines long oligo array comparative ...
technologynetworks

Roche NimbleGen Launches CGH 12x135K Microarrays for Detection of Copy Number Variation

Roche NimbleGen, Inc. has launched NimbleGen Comparative Genomic Hybridization (CGH) microarrays in a 12x135K format for analysis of DNA copy number variation. NimbleGen CGH 12x135K arrays will allow ...
PharmiWeb

OGT unveils the enhanced SureSeq CLL + CNV V3 Panel for deeper insights into CLL progression

Oxford, UK – 02 Dec 2024. Today, OGT announced the launch of its newly updated NGS SureSeq™ CLL + CNV V3 Panel which further incorporates the company’s highly sensitive proprietary bait designs to ...
Seeking Alpha

GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray

STAMFORD, Conn., March 16, 2023 (GLOBE NEWSWIRE) -- GeneDx Holdings Corp. (GeneDx) (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, announced new ...
EurekAlert!

Which tool tells the truth? A head-to-head benchmarking of scRNA-seq CNV methods

Evaluation of scCNV inference methods using a clinical small cell lung cancer (SCLC) dataset. (A) Sensitivity and specificity of the four scCNV inference methods applied to primary and relapse SCLC ...